• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艰难梭菌所致抗生素相关性结肠炎口服及静脉治疗期间粪便中甲硝唑的浓度

Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile.

作者信息

Bolton R P, Culshaw M A

出版信息

Gut. 1986 Oct;27(10):1169-72. doi: 10.1136/gut.27.10.1169.

DOI:10.1136/gut.27.10.1169
PMID:3781329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1433873/
Abstract

Faecal metronidazole and hydroxymetronidazole concentrations measured by high pressure liquid chromatography are reported during 10 episodes of Clostridium difficile colitis in nine patients. Bactericidal faecal concentrations were present in all patients with acute disease receiving oral or intravenous metronidazole, and all responded to therapy. Metronidazole and hydroxymetronidazole concentrations fell as the diarrhoea improved and neither substance was detectable in the faeces of five patients after recovery. This demonstration of intracolonic therapeutic concentrations of metronidazole supports the clinical experience of oral metronidazole being effective in the treatment of antibiotic associated diarrhoea caused by C difficile and also suggests a potential role for intravenous metronidazole in this disease.

摘要

本文报道了通过高压液相色谱法测定的9例患者10次艰难梭菌结肠炎发作期间粪便中甲硝唑和羟甲硝唑的浓度。所有接受口服或静脉注射甲硝唑治疗的急性病患者粪便中均存在杀菌浓度,且所有患者对治疗均有反应。随着腹泻改善,甲硝唑和羟甲硝唑浓度下降,5例患者康复后粪便中均未检测到这两种物质。结肠内甲硝唑治疗浓度的这一证明支持了口服甲硝唑有效治疗艰难梭菌引起的抗生素相关性腹泻的临床经验,也提示了静脉注射甲硝唑在该病中的潜在作用。

相似文献

1
Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile.艰难梭菌所致抗生素相关性结肠炎口服及静脉治疗期间粪便中甲硝唑的浓度
Gut. 1986 Oct;27(10):1169-72. doi: 10.1136/gut.27.10.1169.
2
Intravenous metronidazole for the treatment of Clostridium difficile colitis.
Dis Colon Rectum. 2001 Aug;44(8):1176-80. doi: 10.1007/BF02234641.
3
Update on Clostridium difficile-induced colitis, Part 2.艰难梭菌所致结肠炎的最新进展,第2部分。
Am J Hosp Pharm. 1994 Aug 1;51(15):1892-901; quiz 1958-9.
4
Recurrence of antibiotic-associated pseudomembranous colitis after parenteral metronidazole therapy and cure by oral vancomycin: case report.
Neth J Med. 1981;24(1):10-3.
5
Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.甲硝唑和万古霉素治疗艰难梭菌相关性疾病的临床及微生物学反应比较
Clin Infect Dis. 2008 Jul 1;47(1):56-62. doi: 10.1086/588293.
6
Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide.难辨梭状芽孢杆菌性结肠炎对传统甲硝唑治疗无效:对硝唑尼特的反应
J Antimicrob Chemother. 2007 Apr;59(4):705-10. doi: 10.1093/jac/dkl553. Epub 2007 Mar 2.
7
Metronidazole: an alternate therapy for antibiotic-associated colitis.甲硝唑:抗生素相关性结肠炎的替代疗法。
Gastroenterology. 1982 May;82(5 Pt 1):849-51.
8
The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection.静脉注射甲硝唑联合口服万古霉素可改善艰难梭菌感染的危重症患者的死亡率。
Clin Infect Dis. 2015 Sep 15;61(6):934-41. doi: 10.1093/cid/civ409. Epub 2015 May 29.
9
Clostridium difficile infection.艰难梭菌感染
Annu Rev Med. 1998;49:375-90. doi: 10.1146/annurev.med.49.1.375.
10
[Antibiotic-induced pseudomembranous Clostridium difficile colitis. A new etiopathogenetically definable infectious disease].[抗生素诱发的假膜性艰难梭菌结肠炎。一种新的可从病因学上明确界定的传染病]
Fortschr Med. 1979 Sep 6;97(33):1411-4.

引用本文的文献

1
Evaluating Effects of Antibiotics Across Preclinical Models of the Human Gastrointestinal Microbiota.评估抗生素对人类胃肠道微生物群临床前模型的影响。
Microbiologyopen. 2025 Aug;14(4):e70030. doi: 10.1002/mbo3.70030.
2
The impact of ibezapolstat and other infection-relevant antibiotics on the microbiome of humanized mice.伊贝扎泊司他及其他与感染相关抗生素对人源化小鼠微生物组的影响。
Antimicrob Agents Chemother. 2025 Apr 2;69(4):e0160424. doi: 10.1128/aac.01604-24. Epub 2025 Feb 25.
3
Comparative effectiveness of different therapies for infection in adults: a systematic review and network meta-analysis of randomized controlled trials.成人感染不同治疗方法的比较效果:一项随机对照试验的系统评价和网状Meta分析
Lancet Reg Health Eur. 2025 Jan 5;49:101151. doi: 10.1016/j.lanepe.2024.101151. eCollection 2025 Feb.
4
Epidemiology and Outcomes of Recurrent Infection Among Hematopoietic Cell Transplant Recipients: A Single-center, Retrospective 10-year Study.造血细胞移植受者复发性感染的流行病学及转归:一项单中心、回顾性10年研究
Open Forum Infect Dis. 2024 Oct 1;11(10):ofae570. doi: 10.1093/ofid/ofae570. eCollection 2024 Oct.
5
Is shorter also better in the treatment of Clostridioides difficile infection?在艰难梭菌感染的治疗中,更短的疗程是否更好?
J Antimicrob Chemother. 2024 Jun 3;79(6):1413-1417. doi: 10.1093/jac/dkae119.
6
Improving Infectious Disease Treatment Response via Adherence to Clinical Practice Guidelines.通过遵循临床实践指南改善传染病治疗反应
Antibiotics (Basel). 2024 Jan 4;13(1):51. doi: 10.3390/antibiotics13010051.
7
Antibiotic Resistances of Clostridioides difficile.艰难梭菌的抗生素耐药性。
Adv Exp Med Biol. 2024;1435:169-198. doi: 10.1007/978-3-031-42108-2_9.
8
Antimicrobial Efficacy Evaluations of Metronidazole against Clostridioides difficile Infection using Fecal Pharmacokinetic and Pharmacodynamic Analyses.应用粪便药代动力学和药效学分析评估甲硝唑治疗艰难梭菌感染的抗菌疗效。
Pharm Res. 2023 Jul;40(7):1799-1806. doi: 10.1007/s11095-023-03537-6. Epub 2023 May 24.
9
Gut microbiota interspecies interactions shape the response of Clostridioides difficile to clinically relevant antibiotics.肠道微生物种间相互作用影响艰难梭菌对临床相关抗生素的反应。
PLoS Biol. 2023 May 11;21(5):e3002100. doi: 10.1371/journal.pbio.3002100. eCollection 2023 May.
10
Optimal therapeutic recommendation for Clostridioides difficile infection in pediatric and adolescent populations: a systematic review and meta-analysis.儿童和青少年人群中艰难梭菌感染的最佳治疗推荐:系统评价和荟萃分析。
Eur J Pediatr. 2023 Jun;182(6):2673-2681. doi: 10.1007/s00431-023-04944-y. Epub 2023 Mar 31.

本文引用的文献

1
Treatment of pseudomembranous colitis with oral metronidazole after relapse following vancomycin.
Am J Gastroenterol. 1980 Oct;74(4):359-60.
2
Clinical and laboratory observations in Clostridium difficile colitis.艰难梭菌结肠炎的临床及实验室观察
Am J Clin Nutr. 1980 Nov;33(11 Suppl):2521-6. doi: 10.1093/ajcn/33.11.2521.
3
Treatment and prevention of antimicrobial agent-induced colitis and diarrhae.抗菌药物所致结肠炎和腹泻的治疗与预防。
Gastroenterology. 1980 Aug;79(2):366-72.
4
Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals.克罗恩病患者与健康个体粪便中甲硝唑浓度与拟杆菌属之间的关系。
J Clin Pathol. 1981 Jun;34(6):645-50. doi: 10.1136/jcp.34.6.645.
5
Pseudomembranous colitis. Treatment by metronidazole.伪膜性结肠炎。甲硝唑治疗。
Hepatogastroenterology. 1981 Apr;28(2):120-2.
6
Metronidazole: an alternate therapy for antibiotic-associated colitis.甲硝唑:抗生素相关性结肠炎的替代疗法。
Gastroenterology. 1982 May;82(5 Pt 1):849-51.
7
Pseudomembranous colitis secondary to metronidazole.
Dig Dis Sci. 1983 Jun;28(6):573-4. doi: 10.1007/BF01308162.
8
Metronidazole and antibiotic-associated colitis.甲硝唑与抗生素相关性结肠炎。
Br Med J (Clin Res Ed). 1981 Nov 14;283(6302):1334. doi: 10.1136/bmj.283.6302.1334.
9
Treatment of antibiotic-associated colitis with vancomycin.用万古霉素治疗抗生素相关性结肠炎。
J Antimicrob Chemother. 1984 Dec;14 Suppl D:97-102. doi: 10.1093/jac/14.suppl_d.97.
10
Clostridium difficile colitis.艰难梭菌结肠炎
Adv Intern Med. 1984;29:85-107.